Skip to content

Trevi Therapeutics, Inc. TRVI Change in Other Assets

Change in Other Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$18M0.0%
LQD
Liquidia CorporationLQDA
$4.6M-0.5%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s change in other assets?
Trevi Therapeutics, Inc. (TRVI) reported change in other assets of $2.84M in Q1 2026.
How has Trevi Therapeutics, Inc.'s change in other assets changed year-over-year?
Trevi Therapeutics, Inc.'s change in other assets increased by 369.1% year-over-year, from $605K to $2.84M.
What is the long-term trend for Trevi Therapeutics, Inc.'s change in other assets?
Over 2 years (2021 to 2024), Trevi Therapeutics, Inc.'s change in other assets has grown at a 182.8% compound annual growth rate (CAGR), from -$342K to -$2.74M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.